AUTL vs EW · rev $71.9M vs P/E 47, rev $3.39B
Autolus Therapeutics Ltd (AUTL) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Autolus Therapeutics Ltd (AUTL) is a biotechnology company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported AUTL revenue for 2026-06-30 was $71.9M. Net income was -$110.7M. AUTL currently screens at market cap $614.8M.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
AUTL currently screens at market cap $614.8M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the AUTL and EW stock pages for the full models.
Not investment advice.